PPI-383

· Presidio Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PPI-383, covering 2015-11-26 to 2015-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients [Phase 1]